Evidence map›Paper›PMID 36143099›Full record

ArticleJournal of clinical medicine2022

Evaluation of a Triage Checklist for Mild COVID-19 Outpatients in Predicting Subsequent Emergency Department Visits and Hospitalization during the Isolation Period: A Single-Center Retrospective Study.

Yasuhiro Tanaka, Kazuko Yamamoto, Shimpei Morimoto, Takeshi Nabeshima, Kayoko Matsushima, Hiroshi Ishimoto, Nobuyuki Ashizawa, Tatsuro Hirayama, Kazuaki Takeda, Hiroshi Gyotoku and 22 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 2 institutions in 1 country.

Yasuhiro TanakaDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Kazuko YamamotoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-1357-1676
Shimpei MorimotoClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8102, Japan.
Takeshi NabeshimaDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Kayoko MatsushimaMedical Education Development Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Hiroshi IshimotoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-4374-2894
Nobuyuki AshizawaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Tatsuro HirayamaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Kazuaki TakedaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Hiroshi GyotokuDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-5026-8078
Naoki IwanagaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Shinnosuke TakemotoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Susumu FukahoriDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Takahiro TakazonoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-0696-5386
Hiroyuki YamaguchiDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Takashi KidoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Noriho SakamotoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0002-7577-476X
Naoki HosogayaClinical Research Center, Nagasaki University Hospital, Nagasaki 852-8102, Japan.
Shogo AkabameDepartment of General Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Takashi SugimotoDepartment of General Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Hirotomo YamanashiDepartment of General Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Kosuke MatsuiDepartment of Infectious Diseases, Nagasaki University Hospital, Nagasaki 852-8523, Japan.
Mai IzumidaDepartment of Infectious Diseases, Nagasaki University Hospital, Nagasaki 852-8523, Japan.
Ayumi FujitaInfection Control and Education Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Masato TashiroInfection Control and Education Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0001-7609-7679
Takeshi TanakaInfection Control and Education Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Koya AriyoshiDepartment of Infectious Diseases, Nagasaki University Hospital, Nagasaki 852-8523, Japan.
Akitsugu FurumotoInfectious Diseases Experts Training Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0001-6656-6929
Kouichi MoritaDepartment of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Koichi IzumikawaInfection Control and Education Center, Nagasaki University Hospital, Nagasaki 852-8501, Japan.
Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki 852-8501, Japan.ORCID 0000-0003-3677-2486
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Nagasaki University Hospital · JPNagasaki University · JP

Funding

Japan Agency for Medical Research and Development JP21jm0210087h0002
6 · The paper itself

Abstract

Managing mild illness in COVID-19 and predicting progression to severe disease are concerning issues. Here, we investigated the outcomes of Japanese patients with mild COVID-19, and identified triage risk factors for further hospitalization and emergency department (ED) visits at a single tertiary hospital. A triage checklist with 30 factors was used. Patients recommended for isolation were followed up for 10 days for subsequent ED visits or hospital admission. Overall, 338 patients (median age, 44.0; 45% women) visited the clinic 5.0 days (median) after symptom onset. Thirty-six patients were immediately hospitalized following triage; others were isolated. In total, 72 non-hospitalized patients visited the ED during their isolation, and 30 were hospitalized after evaluation for oxygen desaturation. The median ED visit and hospitalization durations after symptom onset were 5.0 and 8.0 days, respectively. The checklist factors associated with hospitalization during isolation were age > 50 years, body mass index > 25 kg/m2, hypertension, tachycardia with pulse rate > 100/min or blood pressure > 135 mmHg at triage, and >3-day delay in hospital visit after symptom onset. No patients died. Altogether, 80% of patients with mild COVID-19 could be safely isolated at home. Age, BMI, underlying hypertension, date after symptom onset, tachycardia, and systolic blood pressure at triage might be related to later hospitalization.

Indexed as

COVID-19emergency department visithospitalizationoutpatienttriage checklist

Identifiers

PMID36143099
PMCPMC9506197
OpenAlexW4296295825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.